Russell Frank Company’s Haemonetics HAE Stock Holding History

Russell Frank Company’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.14M	Buy	61,218 +15,166	+33%	+$490K	﹤0.01%	1812
2015 Q4	$1.52M	Sell	46,052 -138,442	-75%	-$4.49M	﹤0.01%	1998
2015 Q3	$5.96M	Sell	184,494 -40,083	-18%	-$1.51M	0.01%	1174
2015 Q2	$9.29M	Buy	224,577 +102,900	+85%	+$4.34M	0.01%	1041
2015 Q1	$5.47M	Sell	121,677 -5,892	-5%	-$246K	0.01%	1208
2014 Q4	$4.77M	Sell	127,569 -115,463	-48%	-$4.23M	0.01%	1321
2014 Q3	$8.49M	Buy	243,032 +6,318	+3%	+$225K	0.02%	976
2014 Q2	$8.35M	Buy	236,714 +6,133	+3%	+$205K	0.01%	1023
2014 Q1	$7.51M	Buy	230,581 +57,629	+33%	+$2.2M	0.01%	1044
2013 Q4	$6.59M	Sell	172,952 -2,430	-1%	-$100K	0.01%	1072
2013 Q3	$6.99M	Sell	175,382 -43,723	-20%	-$1.83M	0.01%	1114
2013 Q2	$9.06M	Buy	+219,105	New	+$8.87M	0.02%	908

Other funds holding HAE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Frank Company's HAE Position: Q1 2016 in Review

Russell Frank Company increased its Haemonetics (HAE) stake by 33% in Q1 2016, buying an estimated $490K and bringing the position to 61,218 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Russell Frank Company first reported a position in HAE in Q2 2013 and has held it in 12 quarters since. The position peaked at $9.29M in Q2 2015. 170 funds tracked by Wall St. Rank hold HAE as of Q1 2016.

Russell Frank Company held 61,218 shares of Haemonetics worth $2.14M as of Q1 2016.
Russell Frank Company bought 15,166 Haemonetics shares in Q1 2016, an estimated $490K.
Haemonetics made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1812 holding.
Russell Frank Company first reported a position in Haemonetics in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Haemonetics position peaked at $9.29M in Q2 2015.
170 funds tracked by Wall St. Rank held Haemonetics as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.